BLyS and APRIL in rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

BLyS and APRIL in rheumatoid arthritis.

BLyS and APRIL in rheumatoid arthritis.

http://www.wikidata.org/entity/Q34084521

about

B cell activation factor (BAFF) is a novel adipokine that links obesity and inflammation Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease BAFF and rheumatic autoimmune disorders: implications for disease management and therapy Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium.Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopenia.B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers.Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis.Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.Anti-rheumatic effects of Aconitum leucostomum Worosch. on human fibroblast-like synoviocyte rheumatoid arthritis cells.Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand.Intrarenal production of B-cell survival factors in human lupus nephritis.MiR-30a-3p negatively regulates BAFF synthesis in systemic sclerosis and rheumatoid arthritis fibroblasts.Pathomechanisms in rheumatoid arthritis--time for a string theory?Decoding the differential biomarkers of Rheumatoid arthritis and Osteoarthritis: A functional genomics paradigm to design disease specific therapeutics Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis.Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.Surface APRIL Is Elevated on Myeloid Cells and Is Associated with Disease Activity in Patients with Rheumatoid Arthritis The expression of APRIL in Sjogren's syndrome: aberrant expression of APRIL in the salivary gland.CD8+CD45RA+CCR7+FOXP3+ T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells.An APRIL to remember: novel TNF ligands as therapeutic targets.High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.APRIL, a proliferation-inducing ligand, as a potential marker of lupus nephritis Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.The Characteristics and Significance of Locally Infiltrating B Cells in Lupus Nephritis and Their Association with Local BAFF Expression B lymphocyte stimulator regulates adaptive immune responses by directly promoting dendritic cell maturation.Evidence that cytokines play a role in rheumatoid arthritis.Safety and efficacy of atacicept in combination with rituximab for reducing the signs and symptoms of rheumatoid arthritis: a phase II, randomized, double-blind, placebo-controlled pilot trial.Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort.Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis.Synovial tissues concentrate secreted APRIL.Developments in the scientific understanding of rheumatoid arthritis.Atacicept, a novel B cell-targeting biological therapy for the treatment of rheumatoid arthritis.BAFF: a local and systemic target in autoimmune diseases.TSPAN33 is a novel marker of activated and malignant B cells.Update on Targets of Biologic Therapies for Rheumatoid Arthritis.Cutting-edge issues in celiac disease and in gluten intolerance.The roles of B cells and their interactions with fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis.

P2860

Q28238437-36E3E35E-F9D7-4EEE-B30A-4E9A1D9EE507 Q28248398-1FD556D5-AD24-4C9A-87D5-1DD999876BE9 Q28292058-9C72D3C1-C6F4-401B-8E19-36B7EBC9F514 Q28298650-8047BED9-B8BF-4915-B976-12164A0117BE Q28581828-A3B8AB19-B5A7-4494-A901-A21C3CDC8701 Q33399862-F99831BD-8BF1-465A-A8A3-0B53F00017AD Q33415681-202A0DE0-1C7D-406C-8F81-4577FBD87FBD Q33616360-B2C0C80C-3BB9-4127-86A4-B49B37A62B49 Q33706812-0AB54D08-A6EE-4398-92A0-E2674FBE7A33 Q33803763-285C2BAB-472B-455B-B30F-6E3EFAB80A5A Q33846474-37C0935B-682D-4BE4-9F09-7909A0DF8334 Q34117118-036FE96F-29B4-44CA-BAF2-69CFF325F976 Q34141439-B73362D1-F3D8-4EBF-856C-7386BF9067A0 Q34434727-806BF6F9-7A1B-4726-BF89-10C39B41DAEB Q34498967-AA7D18B1-2A65-4406-B390-E2FFE55CF947 Q34975993-5124F2DC-5544-4383-91B0-95C73C7E0EAD Q35094171-22181F3F-02FC-4EA4-AFF8-A4AFE8A08F1F Q35249619-4403C014-9DA2-475D-9C04-FE0E1C1EFE70 Q35630042-979A5A77-F7ED-4B50-AF26-1DAA14E7276D Q35864231-32560412-0489-4D8F-BAE6-BD8A9D68F4A2 Q36162832-0721C64C-4533-4312-8068-97C2D305891A Q36179565-3E7764C7-24C3-4B6A-B308-34C1E07FB2D0 Q36394955-ACFE70D2-528E-426D-BD5A-140714D62285 Q36800138-1747D7C4-D163-4D8F-9392-0E23E3924CC2 Q36907709-8A4F1D57-6320-497C-BCB7-0729AABB0192 Q36955326-6DDF96B8-22B3-4162-92E9-A7849FDF9A51 Q36960116-A6E05B6A-0989-423B-A1A7-B6770F09DEF3 Q37009908-A05BAAF4-70DE-4B89-B050-08671E7160E4 Q37316594-B958E8E5-566E-41D4-90A1-B1FAC4DAB0F8 Q37326017-8484DBD3-4428-41B2-AD06-377EB4B9C329 Q37350904-348DCE30-8F81-42C1-9225-665A2317B945 Q37357112-C28ADF0E-4493-430A-93AA-CDA2C74913AB Q37454022-9E945AF7-0FCC-475C-A2E1-2ED013E42288 Q37454068-F0A18D9C-29EF-4DEF-9D64-89DE674B3B10 Q37517575-89F20EDC-2183-43B5-90B4-F4E304A54923 Q37593590-D16D1407-218E-4ED0-B764-EDC9D3F47A04 Q37640818-3B99E78B-7507-48B7-B6C5-47192AB4DE40 Q37694304-2D9838D3-9A28-44F5-9E5E-6B574EEC2812 Q37823418-A7F5BD8E-6FBE-44CD-8C08-7F2C2AF71DD6 Q37835631-D46D3B5B-9AD4-4CF2-A619-1294D0AB881E

P2860

BLyS and APRIL in rheumatoid arthritis.

http://www.wikidata.org/entity/Q34084521

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

BLyS and APRIL in rheumatoid arthritis.

@ast

BLyS and APRIL in rheumatoid arthritis.

@en

BLyS and APRIL in rheumatoid arthritis.

@nl

type

label

BLyS and APRIL in rheumatoid arthritis.

@ast

BLyS and APRIL in rheumatoid arthritis.

@en

BLyS and APRIL in rheumatoid arthritis.

@nl

prefLabel

BLyS and APRIL in rheumatoid arthritis.

@ast

BLyS and APRIL in rheumatoid arthritis.

@en

BLyS and APRIL in rheumatoid arthritis.

@nl

P1433

Q34084521-B40479E3-6B60-4F5B-9D97-EAD010CB8726

P1476

Q34084521-A6428DE8-9302-46DD-AB48-4FA4A823FB5B

P2093

Q34084521-04BED465-ABB0-4C33-94FC-BD1FE28570C2

Q34084521-2957EF04-47AD-4656-8535-04616952C54E

Q34084521-3CFEE81B-A96B-4BF7-9F2C-C7FE592C1A25

Q34084521-6AB8B3A7-EDF5-406C-97FD-1017876EB8BC

Q34084521-6EB3E1A9-8494-4C34-A484-960C19379EE6

Q34084521-7964E03F-D188-4104-8FF5-EB9A7CBBE66A

Q34084521-9B6623C8-B95C-4BC6-8161-F57EA1ACC7A9

P2860

Q34084521-02062DFD-E092-4DE8-B8B5-321D04336DF5

Q34084521-077F76DE-D49F-4AFB-ABE7-D26D30A90280

Q34084521-15660B39-08DB-4EAC-9C4C-C69D2DD22CE1

Q34084521-172D0162-5E8D-4368-8298-F276E0CAC0C3

Q34084521-2B884113-6306-4C48-8DA9-7364952002C8

Q34084521-2E7900C3-6F38-4498-8E29-FA7304F2FB83

Q34084521-33DFF562-C658-4C69-8AEB-128F3D5DAFC3

Q34084521-3516D599-5D27-4E13-94FA-2F25C97D9152

Q34084521-371C02B2-7F03-43F8-80C4-AE4DA9768FBF

Q34084521-394635CC-1520-4372-A998-C927A9A7AA96

P304

Q34084521-87099532-E071-4C66-81D1-EFF4459EEE52

P31

Q34084521-E8684342-D973-4FEA-BE36-6288123DAF56

P356

Q34084521-5DBABB8E-A8BA-4B6A-B36B-118589CAC85E

P407

Q34084521-ED804C10-1212-433F-B144-1B962C01FC84

P433

Q34084521-2DBA735F-49F2-43AA-A7A0-9F3F89662F80

P478

Q34084521-7E3B2B05-B478-4213-942D-476AFD5F1D44

P577

Q34084521-C1E55DD6-7773-43E2-A24A-EC25E6C765B7

P5875

Q34084521-067E617F-9C65-4932-A5A1-0400AEE8F715

P698

Q34084521-679288DD-2649-42C9-A75F-2BFAC45C3236

P932

Q34084521-3E1CDABF-0845-4762-BA47-2CD673D3E2A0

P356

P1433

Journal of Clinical Investigation

P1476

BLyS and APRIL in rheumatoid arthritis.

@en

P2093

Cornelia M Weyand

http://www.w3.org/2001/XMLSchema#string

Jörg J Goronzy

http://www.w3.org/2001/XMLSchema#string

Paul J Kurtin

http://www.w3.org/2001/XMLSchema#string

Richard J Bram

http://www.w3.org/2001/XMLSchema#string

Seisuke Takemura

http://www.w3.org/2001/XMLSchema#string

Thorsten M Seyler

http://www.w3.org/2001/XMLSchema#string

Yong W Park

http://www.w3.org/2001/XMLSchema#string

P2860

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth

CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells

APRIL modulates B and T cell immunity

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

SLE--systemic lupus erythematosus: a BLySful, yet BAFFling, disorder

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

TALL-1 is a novel member of the TNF family that is down-regulated by mitogens

Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase

P304

3083-3092

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI25265

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7526548

http://www.w3.org/2001/XMLSchema#string

P698

16239971

http://www.w3.org/2001/XMLSchema#string

P932

1257539

http://www.w3.org/2001/XMLSchema#string